These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33670631)

  • 21. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
    Baumann L; Goldberg DJ; Stein Gold L; Tanghetti EA; Lain E; Kaufman J; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Mar; 17(3):290-298. PubMed ID: 29537447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin compatibility and efficacy of a cosmetic skin care regimen with licochalcone A and 4-t-butylcyclohexanol in patients with rosacea subtype I.
    Schoelermann AM; Weber TM; Arrowitz C; Rizer RL; Qian K; Babcock M
    J Eur Acad Dermatol Venereol; 2016 Feb; 30 Suppl 1():21-7. PubMed ID: 26805419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Topical Timolol 0.5% in the Treatment of Acne and Rosacea: A Multicentric Study.
    Al Mokadem SM; Ibrahim AM; El Sayed AM
    J Clin Aesthet Dermatol; 2020 Mar; 13(3):22-27. PubMed ID: 32308793
    [No Abstract]   [Full Text] [Related]  

  • 24. The toxic edge-A novel treatment for refractory erythema and flushing of rosacea.
    Friedman O; Koren A; Niv R; Mehrabi JN; Artzi O
    Lasers Surg Med; 2019 Apr; 51(4):325-331. PubMed ID: 30311683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.
    Layton AM; Schaller M; Homey B; Hofmann MA; Bewley AP; Lehmann P; Nohlgård C; Sarwer DB; Kerrouche N; Ma YM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2405-10. PubMed ID: 26416154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.
    Fowler J; Jackson M; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M
    J Drugs Dermatol; 2013 Jun; 12(6):650-6. PubMed ID: 23839181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea.
    Ortiz A; Elkeeb L; Truitt A; Hindiyeh R; Aquino L; Tran M; Weinstein G
    J Drugs Dermatol; 2009 May; 8(5):459-62. PubMed ID: 19537369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
    Kircik LH; DuBois J; Draelos ZD; Werschler P; Grande K; Cook-Bolden FE; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Jan; 17(1):97-105. PubMed ID: 29320594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of facial vascular skin diseases with a 577-nm pro-yellow laser.
    Mohamed EM; Mohamed Tawfik K; Hassan Ahmad W
    J Cosmet Dermatol; 2019 Dec; 18(6):1675-1679. PubMed ID: 31033204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of Cetaphil Gentle Skin Cleanser on the skin barrier of patients with rosacea.
    Draelos ZD
    Cutis; 2006 Apr; 77(4 Suppl):27-33. PubMed ID: 16706247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Preliminary Clinical Evaluation of a Topical Product for Reducing Slight Rosacea Imperfections.
    Maggioni D; Cimicata A; Praticò A; Villa R; Bianchi FM; Busoli Badiale S; Angelinetta C
    Clin Cosmet Investig Dermatol; 2020; 13():299-308. PubMed ID: 32368125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Topical Cytokinin Improves Coarse Wrinkles and Skin Roughness Without Skin Irritation.
    Garcia RL; McCullough JL; Reece B; Massino FJ
    J Drugs Dermatol; 2018 Jul; 17(7):772-779. PubMed ID: 30005100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxocobalamin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.
    Huang YW; Huang HP; Hsu CK; Lee JY
    J Clin Aesthet Dermatol; 2022 Jun; 15(6):42-45. PubMed ID: 35783562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea.
    Bloom BS; Payongayong L; Mourin A; Goldberg DJ
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S9-16. PubMed ID: 25548852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of topical spironolactone 5% cream in the treatment of acne: A pilot study.
    Ayatollahi A; Samadi A; Bahmanjahromi A; Robati RM
    Health Sci Rep; 2021 Sep; 4(3):e317. PubMed ID: 34250269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-fluence 585 nm Q-switched Nd:YAG laser: a novel laser treatment for post-acne erythema.
    Panchaprateep R; Munavalli G
    Lasers Surg Med; 2015 Feb; 47(2):148-55. PubMed ID: 25645645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of conditioned media of adipose-derived stem cells combined with ablative carbon dioxide fractional resurfacing for atrophic acne scars and skin rejuvenation.
    Zhou BR; Zhang T; Bin Jameel AA; Xu Y; Xu Y; Guo SL; Wang Y; Permatasari F; Luo D
    J Cosmet Laser Ther; 2016 Jun; 18(3):138-48. PubMed ID: 26735291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea.
    Jackson JM; Fowler J; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M;
    J Drugs Dermatol; 2014 Jun; 13(6):699-704. PubMed ID: 24918560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resurfacing of pitted facial acne scars using Er:YAG laser with ablation and coagulation mode.
    Jeong JT; Park JH; Kye YC
    Aesthetic Plast Surg; 2003; 27(2):130-4. PubMed ID: 14629067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the Efficacy and Safety of 30% Supramolecular Salicylic Acid Peeling for Papulopustular Rosacea Treatment.
    Xu L; Yao B; Xu T; Huang H
    Indian J Dermatol; 2022; 67(5):625. PubMed ID: 36865859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.